Vascular Cognitive Disorder. A Biological and Clinical Overview

  title={Vascular Cognitive Disorder. A Biological and Clinical Overview},
  author={Leontino Battistin and Annachiara Cagnin},
  journal={Neurochemical Research},
Although vascular dementia (VaD) represents the second most common cause of dementia after Alzheimer’s disease (AD) in the elderly, and is referred as the “silent epidemic of the twenty-first century”, there is still a controversy on terminology, classification and diagnostic criteria of VaD. The diagnosis of VaD resides in clinical criteria determining a cognitive impairment, the presence of cerebrovascular disease and, only in the case of post-stroke dementia or multi-infarct dementia, a… 
Diagnosis of vascular cognitive impairment and its main categories
The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline
It is proposed that understanding and targeting the biological mechanisms of VCID can have a similarly positive impact on public health.
The effect of vascular risk factors in dementia of the Alzheimer's type
The aim of this study was to investigate the relationship between vascular risk factors and cognitive function in a large cohort of 768 cognitively healthy older individuals drawn from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing.
Biomarkers in vascular dementia: A recent update
Genetic Markers in Biological Fluids for Aging-Related Major Neurocognitive Disorder
The current diagnostic criteria consider cognitive decline leading to major NCD or dementia as a progressive degenerative process with an underlying neuropathology that begins before the manifestation of symptoms that may, in turn, accelerate the neurodegenerative process and its resultant behavioral and functional disorders.
The aim of this review is to study types, risk factors involved, understand the underlying mechanisms in the pathogenesis of dementia and new therapeutic approaches, thus maximize opportunities for the search for new and effective therapeutic strategies.
Peripheral Blood Mononuclear Cells as a Laboratory to Study Dementia in the Elderly
The role of biomarkers in AD is addressed with a focus on the notion that PBMCs may serve as a peripheral laboratory to find molecular signatures that could aid in differential diagnosis with other forms of dementia and in monitoring of disease progression.
Post-stroke dementia – a comprehensive review
PSD is proposed as a label for any dementia following stroke in temporal relation and no specific biomarkers have been proven to robustly discriminate vulnerable patients (‘at risk brains’) from those with better prognosis or to discriminate Alzheimer’s disease dementia from PSD.
Qualitative Analysis of Mini Mental State Examination Pentagon in Vascular Dementia and Alzheimer's Disease: A Longitudinal Explorative Study.
  • V. Lo Buono, L. Bonanno, S. Marino
  • Medicine, Psychology
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
  • 2018
From Chronic Cerebral Hypoperfusion to Alzheimer-Like Brain Pathology and Neurodegeneration
It appears that CCH promotes neurodegeneration and AD through multiple mechanisms, including induction of oxidative stress, Aβ accumulation and aggravation, tau hyperphosphorylation, synaptic dysfunction, neuronal loss, white matter lesion, and neuroinflammation.


Vascular dementia
These criteria for the diagnosis of vascular dementia are intended as a guide for case definition in neuroepidemiologic studies, stratified by levels of certainty (definite, probable, and possible).
The enigma of vascular cognitive disorder and vascular dementia
No validated neuropathologic criteria for VaD are available, and a large variability across laboratories still exists in the procedures for morphologic examination and histology techniques, suggesting different pathogenesis of both types of lesions.
Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia
Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
Criteria for the diagnosis of ischemic vascular dementia (IVD) broaden the conceptualization of vascular dementia, include the results of neuroimaging studies, emphasize the importance of neuropathologic confirmation, refine nosology, and identify areas that require further research.
Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease
The results show that the frequency of the ApoE ɛ4 allele in patients over 70 years old with clinically diagnosed VaD and VMCI does not differ significantly from that of controls, and that the risk of having late‐onset AD or non‐vascular cognitive impairment is higher than expected.
Subcortical vascular dementia
A profile of equal impairment on tests of executive control and memory along with radiologic evidence involving about one-fourth of the cerebral white matter as measured by the Leukoaraiosis Scale may be sufficient for a diagnosis of subcortical vascular dementia.
Vascular cognitive impairment
The concept of VCI is reviewed in terms of the evidence base surrounding diagnosis, clinical features, pathophysiology, and management and to make some recommendations regarding further research in the area.
Cholesterol as a risk factor for Alzheimer's disease – epidemiological evidence
This review aims at presenting current epidemiological data on serum cholesterol levels and dietary fat intake as risk factors for dementia/AD, and at discussing the reasons and significance of contradictions between various studies.
NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia
The neuroimaging component of the NINDS AIREN criteria does not distinguish between older patients with and without poststroke dementia.
Lipid metabolism in cognitive decline and dementia